The annual incidence of both pancreatic and liver cancer is outlined below, which translates to a global opportunity of more than US$2 billion for pancreatic treatment and US$1.4 billion for liver cancer assuming a US$25,000 price per dose of OncoSilTM.
https://www.google.com/amp/s/finfeed.com/small-caps/biotech/oncosil-verge-ce-mark-approval/amp/
The annual incidence of both pancreatic and liver cancer is...
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.001(25.0%) |
Mkt cap ! $11.27M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.4¢ | $9.921K | 2.075M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 36 | 15119267 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 2333627 | 4 |
View Market Depth
| Last trade - 15.56pm 29/04/2024 (20 minute delay) ? |
|
|||||
|
Last
0.5¢ |
Change
0.001 ( 12.5 %) |
||||
| Open | High | Low | Volume | ||
| 0.5¢ | 0.5¢ | 0.5¢ | 484933 | ||
| Last updated 15.52pm 29/04/2024 ? | |||||
| OSL (ASX) Chart |